Difficulty: Medium
Average Score: 62%
Practice
The client is taking a medication that is an ADP receptor blocker for the prevention of ischemic stroke. What might this medication be?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Plavix. Plavix, also known as clopidogrel, is an ADP receptor blocker that is commonly used for the prevention of ischemic stroke. Clopidogrel works by inhibiting platelet aggregation, thereby reducing the risk of blood clot formation that could lead to a stroke.
Now, let's analyze why the other options are incorrect:
A) Aspirin: While aspirin is also commonly used for stroke prevention, it works through a different mechanism by inhibiting cyclooxygenase and preventing the formation of thromboxane A2.
B) Heparin: Heparin is an anticoagulant that works by potentiating the activity of antithrombin III and inhibiting the coagulation cascade. It is not an ADP receptor blocker.
C) Warfarin: Warfarin is a vitamin K antagonist that interferes with the clotting factors in the liver. It is used for long-term anticoagulation but is not an ADP receptor blocker like Plavix.
Educational Context:
Understanding the mechanisms of action of different cardiovascular drugs is crucial for healthcare professionals in providing safe and effective care to patients. Knowing which medications work through specific pathways allows for appropriate selection, monitoring, and management of patients receiving these treatments. In the case of stroke prevention, selecting the right medication based on its mechanism of action can significantly impact patient outcomes.
Now, let's analyze why the other options are incorrect:
A) Aspirin: While aspirin is also commonly used for stroke prevention, it works through a different mechanism by inhibiting cyclooxygenase and preventing the formation of thromboxane A2.
B) Heparin: Heparin is an anticoagulant that works by potentiating the activity of antithrombin III and inhibiting the coagulation cascade. It is not an ADP receptor blocker.
C) Warfarin: Warfarin is a vitamin K antagonist that interferes with the clotting factors in the liver. It is used for long-term anticoagulation but is not an ADP receptor blocker like Plavix.
Educational Context:
Understanding the mechanisms of action of different cardiovascular drugs is crucial for healthcare professionals in providing safe and effective care to patients. Knowing which medications work through specific pathways allows for appropriate selection, monitoring, and management of patients receiving these treatments. In the case of stroke prevention, selecting the right medication based on its mechanism of action can significantly impact patient outcomes.